Stay updated with breaking news from Brian Derubertis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In patients with severe artery blockage in the lower leg, an artery-supporting device called a resorbable scaffold is superior to angioplasty, according to the results of a large international clinical trial co-led by researchers at Weill Cornell Medicine and NewYork-Presbyterian.
Abbott's landmark LIFE-BTK randomized clinical trial met its primary safety and effectiveness endpoints, demonstrating that Esprit BTK offers significant advancements in opening and keeping blocked arteries below-the-knee open compared to the standard of care, balloon angioplasty
Abbott (NYSE:ABT) today announced data supporting its Esprit BTK everolimus-eluting resorbable scaffold system.
Abbott's new investigational drug-eluting Esprit BTK (below-the-knee) resorbable scaffold is made of naturally dissolving material that disappears over time...
Abbott's new investigational drug-eluting Esprit BTK resorbable scaffold is made of naturally dissolving material that disappears over time after it's opened a clogged arteryThere is a significant...